Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Filings indexed 2,868 across all filing types
Latest filing 2015-02-11 Regulatory Filings
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos ontvangt €1,6 miljoen subsidie van het IWT voor onderzoek naar hepatitis B
Regulatory Filings Classification · 95% confidence The document is titled 'Persbericht' (Press Release) dated February 11, 2015, announcing that Galapagos NV received a €1.6 million subsidy from IWT for hepatitis B research. It details the research program, collaborators, background on the disease, and information about the funding agency (IWT) and the company (Galapagos). This format—a formal announcement of a specific, non-financial event (a grant/subsidy) intended for the public and investors—is characteristic of a general regulatory announcement or press release that doesn't fit the specific financial report categories (like 10-K, IR, ER). Since it is a formal announcement that doesn't fit the other specific categories (like DIV, CAP, MANG, etc.), the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements.
2015-02-11 Dutch
BNP Paribas notify of 5.08% shareholding in Galapagos
Major Shareholding Notification Classification · 99% confidence The document is titled "BNP Paribas notify of 5.08% shareholding in Galapagos" and explicitly states that Galapagos NV received a "transparency notification from BNP Paribas" regarding the holding of 5.08% of outstanding shares. This directly relates to changes in significant share ownership thresholds, which aligns perfectly with the definition for Major Shareholding Notification (MRQ). The document is a notification of a change in ownership, not a general regulatory filing (RNS) or a report itself.
2015-02-09 English
BNP Paribas notify of 5.08% shareholding in Galapagos
Major Shareholding Notification Classification · 99% confidence The document is a press release from Galapagos NV, dated February 9, 2015, announcing that it received a notification of a significant shareholding (5.08%) from BNP Paribas. The text explicitly references compliance with Belgian transparency legislation regarding the disclosure of important shareholdings ('kennisgeving van belangrijke deelneming'). This type of filing, which reports changes in significant ownership thresholds by external parties, directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is a regulatory disclosure, MRQ is more specific than the general RNS category.
2015-02-09 English
BNP Paribas geeft kennis van deelneming van 5,08% in Galapagos
Major Shareholding Notification Classification · 99% confidence The document is a formal announcement dated February 9, 2015, titled "BNP Paribas geeft kennis van deelneming van 5,08% in Galapagos" (BNP Paribas notifies of 5.08% stake in Galapagos). It explicitly states that Galapagos received a notification of a significant shareholding from BNP Paribas, referencing Belgian transparency legislation regarding the disclosure of major shareholdings. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2015-02-09 Dutch
2015_05-NL.pdf
Major Shareholding Notification Classification · 98% confidence The document is a formal announcement dated February 9, 2015, titled "BNP Paribas geeft kennis van deelneming van 5,08% in Galapagos" (BNP Paribas notifies of 5.08% stake in Galapagos). It explicitly states that Galapagos received a notification of a significant shareholding from BNP Paribas, referencing Belgian transparency legislation regarding the disclosure of major shareholdings. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2015-02-09 Dutch
Galapagos receives €2.5 million IWT grant for antibiotic research
Regulatory Filings Classification · 95% confidence The document is a press release dated January 22, 2015, announcing that Galapagos NV received a €2.5 million grant from the Flemish Agency for Innovation through Science and Technology (IWT) to support antibiotic research (GLPG1492). It details the research project, the scientific background on MRSA, and provides company pipeline information. This type of announcement, focusing on specific funding, research milestones, or grants that are not standard quarterly/annual financial results, management changes, or major corporate actions (like M&A or share issues), fits best under a general regulatory announcement or news release category. Since it is a specific, non-financial operational update, and does not fit the definitions for ER, IR, CAP, MANG, or LTR, the most appropriate classification is the general Regulatory Filings category (RNS), which serves as a fallback for specific news releases not covered elsewhere.
2015-01-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.